Insider Transactions Reported by 20 Insiders of Nurix Therapeutics, Inc.

Symbol
NRIX on Nasdaq
Location
Brisbane, CA

Insiders trading volume in the past year

Nurix Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures III, L.P. 10%+ Owner $35,104,359 06 May 2021
COLUMN GROUP L P 10%+ Owner $14,431,862 07 May 2021
Hans van Houte Chief Financial Officer $1,491,608 -$389,328 -21% 10 Feb 2026
Christine Ring Chief Legal Officer $1,236,651 -$1,341,128 -52% 02 Mar 2026
Pierre Beaurang Chief Business Officer $1,210,335 10 Aug 2021
Gwenn Hansen Chief Scientific Officer $799,068 -$224,134 -22% 10 Feb 2026
Stefani Wolff EVP and COO $145,701 30 Apr 2023
JULIA P. GREGORY Director $19,995 17 Sep 2025
Lori Anne Kunkel Director $0 19 May 2025
Edward C. Saltzman Director 19 May 2025
Jeffrey K. Tong Director, 10%+ Owner 06 May 2021
ROGER D. DANSEY Director 06 Nov 2025
SANDS ARTHUR T. President, CEO, Director 10 Feb 2026
Anil Kapur Director 19 May 2025
CLAY B. SIEGALL Director 05 May 2022
Roy D. Baynes Director 19 May 2025
Judith A. Reinsdorf Director 19 May 2025
Paul M. Silva Director 19 May 2025
David L. Lacey Director 19 May 2025
Leon Chen Director 06 May 2021

Recent Insider Transactions by Companies or Individuals for Nurix Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.